Ardelyx
Ardelyx is a California-based biopharmaceutical firm that develops and commercializes minimally-systemic therapeutics for the treatment of cardiorenal and gastrointestinal diseases.
Business Model:
Revenue: $9M
Employees: 51-200
Industries / Tags:
Detailed Ardelyx Information
Geographic Data
Address: 34175 Ardenwood Boulevard
City: Fremont
State: CA
Zip: 94555
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$20M
Raised Total:$245M
Social
Metrics
2,856,756Website Global Rank
5,956Website Monthly Traffic
Twitter Followers
Description
Ardelyx is a California-based biopharmaceutical firm that develops and commercializes minimally-systemic therapeutics for the treatment of cardiorenal and gastrointestinal diseases.
Contact Phone:
+15107451700
Contact Email:
Ardelyx went public on 6/20/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/20/2014
IPO Valuation:
$238M
Ticker Symbol:
ARDX
IPO Price:
$14/share
Amount Raised:
$60M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
